Cardiex Initiates Unmarketable Parcel Share Buy-Back
Cardiex Limited has announced an unmarketable parcel share buy-back, allowing shareholders with holdings valued at less than A$500 to sell their shares back to the company at A$0.03 per share. This initiative aims to streamline operations by canceling these shares once transferred. Eligible shareholders must submit a retention form by October 13, 2025, if they wish to retain their shares, with the buy-back concluding by October 23, 2025. Cardiex focuses on advancing medical technology for vascular health and is listed on the ASX (AU:CDX).
Tip Ranks·